Gabrielsen Discusses New State and Federal Efforts to Curb Prescription Opioid Abuse
08 February 2018
Associate Lindsey Gabrielsen is quoted in a Bloomberg BNA Health Law Resource Center article, “Doctors Feel the Pinch of Anti-Opioid Efforts,” about doctors’ efforts to comply with new state and federal limits on prescribing opioids.
Gabrielsen said the new limits can trip up physicians who don’t keep careful track of their prescribing history. “These government initiatives use data mining and data sharing to identify and target those physicians who prescribe more opioids than their peers, making them potential targets for government investigation,” she said.
She said doctors can take a number of practical steps to manage their opioid prescription risks, including taking the time to understand their state’s opioid prescribing laws. Focusing on documentation compliance is critical, she added. “If the government issues an investigatory subpoena for records, prescribers must be able to produce complete patient records containing notes with patient history, examination, and prescription information,” she said.
Gabrielsen said the new limits can trip up physicians who don’t keep careful track of their prescribing history. “These government initiatives use data mining and data sharing to identify and target those physicians who prescribe more opioids than their peers, making them potential targets for government investigation,” she said.
She said doctors can take a number of practical steps to manage their opioid prescription risks, including taking the time to understand their state’s opioid prescribing laws. Focusing on documentation compliance is critical, she added. “If the government issues an investigatory subpoena for records, prescribers must be able to produce complete patient records containing notes with patient history, examination, and prescription information,” she said.
Related News
03 May 2024
In the News
Jeff Symons’ Move to Foley Featured in Press
Foley & Lardner LLP partner Jeff Symons is featured in legal press for his recent arrival to the firm
03 May 2024
In the News
Nathaniel Lacktman on Healthleaders Podcast– ‘We’re seeing maturity in the telemedicine market’
Foley & Lardner LLP partner Nathaniel Lacktman discussed the upcoming American Telemedicine Association’s annual conference, new developments in telemedicine and digital health, the regulatory context, and the prospects for the industry’s future
02 May 2024
In the News
Jennifer Hennessy on American Privacy Rights Act – ‘This law does have teeth’
Foley & Lardner LLP partner Jennifer Hennessy assesses the prospects of what could be the first federal data privacy law passed in the United States